HEALTHY EXTRACTS INC. 10-K

ITEM 5 - MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Our common stock is quoted on an unsolicited basis on the OTCQB tier of the marketplace maintained by OTC Markets Group, Inc. under the symbol “HYEX.” Our stock is piggyback qualified for broker-dealer quotations. Our common stock trades on a limited or sporadic basis and should not be deemed to constitute an established public trading market. There is no assurance that there will be liquidity in the common stock. The following table sets forth the high and low closing price for each quarter within the fiscal years ended December 31, 2025 and 2024, as provided by Nasdaq, after giving effect to the 1-for-120 reverse stock split on December 29, 2023. The information reflects prices between dealers, and does not include retail markup, markdown, or commission, and may not represent actual transactions. Fiscal Year Ended Transaction Prices December 31, Period High Low 2026 First Quarter (through February 28, 2026) $ 2.35 $ 1.68 2025 Fourth Quarter $ 2.25 $ 0.81 Third Quarter $ 3.35 $ 1.60 Second Quarter $ 4.25 $ 1.50 First Quarter $ 2.51 $ 1.26 2024 Fourth Quarter $ 3.58 $ 0.87 Third Quarter $ 4.29 $ 1.01 Second Quarter $ 2.50 $ 0.91 First Quarter $ 4.05 $ 1.03 The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosure relating to the market for penny stocks in connection with trades in any stock defined as a penny stock. The Commission has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to a few exceptions which we do not meet. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated therewith. Holders As of March 31, 2026, there were 16,890,868 shares of our common stock issued and outstanding and held by approximately 110 holders of record, not including shares held in “street name” in brokerage accounts which is unknown. Dividend Policy We have not paid any dividends on our common stock and do not expect to do so in the foreseeable future. We intend to apply our earnings, if any, in expanding our operations and related activities. The payment of cash dividends in the future will be at the discretion of the Board of Directors and will depend 44 upon such factors as earnings levels, capital requirements, our financial condition and other factors deemed relevant by the Board of Directors. Securities Authorized for Issuance under Equity Compensation Plans On December 26, 2022, we approved the Healthy Extracts Inc. 2022 Equity Incentive Plan and set aside 433,334 shares of our common stock for issuance thereunder. Plan category Number of securities to be issued upon exercise of outstanding options, warrants and rights Weighted-average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)). (a) (b) (c) Equity compensation plans approved by security holders (options) 15,833 $6.00 88,334 (RSU’s) -0- -0- Equity compensation plans not approved by security holders -0- -0- -0- Total 15,833 $6.00 88,334 Recent Issuance of Unregistered Securities There have been no events which are required to be reported under this Item. ITEM 6 – RESERVED As a smaller reporting company, we are not required to provide the information required by this Item. 45